Lal LS - Search Results

1

Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer center setting.

Lal LS, Hung F, Feng C, Zhuang A, DaCosta Byfield S, Miller LA, Adamus A, Arbuckle R. Lal LS, et al. J Oncol Pharm Pract. 2011 Jun;17(2):131-5. doi: 10.1177/1078155209360874. Epub 2010 Feb 23. J Oncol Pharm Pract. 2011. PMID: 20179166

2

Disparities in outpatient antidepressant prescribing patterns and determinants of resource utilization at a tertiary care cancer center.

Lal LS, Miller LA, Arbuckle R, Hung F, Feng C, Adamus A, Fisch MJ. Lal LS, et al. J Support Oncol. 2009 Nov-Dec;7(6):237-44. J Support Oncol. 2009. PMID: 20380332

3

Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center.

Lal LS, Zhuang A, Hung F, Feng C, Arbuckle R, Fisch MJ. Lal LS, et al. Support Care Cancer. 2012 May;20(5):983-9. doi: 10.1007/s00520-011-1170-4. Epub 2011 Apr 26. Support Care Cancer. 2012. PMID: 21519946

4

Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center.

Felder TM, Lal LS, Bennett CL, Hung F, Franzini L. Felder TM, et al. Among authors: lal ls. Community Oncol. 2011 Jun 1;8(6):279-286. doi: 10.1016/S1548-5315(12)70023-2. Epub 2012 Feb 10. Community Oncol. 2011. PMID: 22879815 Free PMC article.

5

Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients.

Lal LS, Raju A, Miller LA, Chen H, Arbuckle R, Sansgiry SS. Lal LS, et al. Support Care Cancer. 2010 Feb;19(2):251-9. doi: 10.1007/s00520-009-0811-3. Epub 2010 Jan 26. Support Care Cancer. 2010. PMID: 20101414

6

Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.

Jonasch E, Lal LS, Atkinson BJ, Byfield SD, Miller LA, Pagliaro LC, Feng C, Tannir NM. Jonasch E, et al. Among authors: lal ls. BJU Int. 2011 Mar;107(5):741-747. doi: 10.1111/j.1464-410X.2010.09626.x. Epub 2010 Sep 21. BJU Int. 2011. PMID: 21355978 Free PMC article.

7

Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases.

Lal LS, Byfield SD, Chang EL, Franzini L, Miller LA, Arbuckle R, Reasonda L, Feng C, Adamus A, Swint JM. Lal LS, et al. Am J Clin Oncol. 2012 Feb;35(1):45-50. doi: 10.1097/COC.0b013e3182005a8f. Am J Clin Oncol. 2012. PMID: 21293245 Clinical Trial.

8

Retrospective evaluation of weekly paclitaxel hypersensitivity reactions reported utilizing an electronic medical record system at a tertiary cancer center.

Lal LS, Gerber DL, Lau J, Dana W. Lal LS, et al. Support Care Cancer. 2009 Oct;17(10):1311-5. doi: 10.1007/s00520-009-0588-4. Epub 2009 Jan 30. Support Care Cancer. 2009. PMID: 19184123

9

Low rates of hepatitis B virus screening at the onset of chemotherapy.

Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor ME. Hwang JP, et al. Among authors: lal ls. J Oncol Pract. 2012 Jul;8(4):e32-9. doi: 10.1200/JOP.2011.000450. Epub 2012 Jun 12. J Oncol Pract. 2012. PMID: 23180996 Free PMC article.

10

Impact of safety concerns and regulatory changes on the usage of erythropoiesis-stimulating agents and RBC transfusions.

Vadhan-Raj S, Zhou X, Sizer K, Lal L, Wang X, Roquemore J, Shi W, Benjamin RS, Lichtiger B. Vadhan-Raj S, et al. Oncologist. 2010;15(12):1359-69. doi: 10.1634/theoncologist.2010-0293. Epub 2010 Dec 15. Oncologist. 2010. PMID: 21159724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters